WRW.CN - Winston Resources Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.0300
0.0000 (0.00%)
At close: 9:48AM EST
Stock chart is not supported by your current browser
Previous Close0.0300
Open0.0300
Bid0.03 x 0
Ask0.04 x 0
Day's Range0.0300 - 0.0300
52 Week Range0.0150 - 0.5600
Volume5,500
Avg. Volume23,004
Market Cap754,014
Beta (3Y Monthly)2.77
PE Ratio (TTM)0.57
EPS (TTM)0.05
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group7 months ago

    IIROC Trade Resumption - WRW

    IIROC Trade Resumption - WRW

  • CNW Group8 months ago

    Winston Resources Provides Update Regarding Distribution of Common Shares of Abattis Bioceuticals to Shareholders

    VANCOUVER , June 1, 2018 /CNW/ - Winston Resources Inc. ("Winston" or the "Company") (CSE: WRW) (FSE:WNT) is pleased to announce that further to its news release on May 24, 2018 , the Company intends to complete the distribution (the "Distribution") of a total of 15,000,000 common shares (the "Abattis Shares") of Abattis Bioceuticals Corp. ("Abattis") on or about June 8, 2018 on a pro rata basis to the Company's shareholders of record as of January 23, 2018 (the "Winston Shareholders"). Each Winston Shareholder is entitled to receive approximately 0.5968 of one Abattis Share for each common share of Winston held.

  • CNW Group8 months ago

    Winston Resources Announces Distribution of Common Shares of Abattis Bioceuticals to Winston Resources Shareholders

    FSE:WNT) is pleased to announce that further to its news release on January 11, 2018 that the Company intends to distribute the 15,000,000 common shares (the "Abattis Shares") of Abattis Bioceuticals Corp. ( "Abattis") on a pro rata basis to the holders of record as of January 23, 2018 (the "Winston Shareholders") of common shares of Winston (the "Proposed Distribution").  The Abattis Shares are subject to a hold period expiring May 25, 2018 . Winston acquired the Abbatis Shares pursuant to the terms of an assignment agreement dated January 10, 2018 (the "Assignment Agreement") between Winston and Abbatis relating to the acquisition of GT Therapeutics Corporation, dba Green Tree Therapeutics ("GTT").  In connection with the closing of the acquisition of GTT by Abattis on January 25, 2018 , the Company was issued the Abattis Shares.